BMI role in treatment of infertile patients with polycystic ovary syndrome

International Congress Series

Volumn 1271, Issue C, 2004, Pages 34-37

  Tahmasbi Rad, Morva ^a  

^a Iranian Association of Surgeons   (Iran)

Author keywords

BMI; Metformin; Polycystic ovary syndrome

Indexed keywords

EID: 84857226776     PISSN: 05315131     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.ics.2004.05.156     Document Type: Article

References (11)

1. Franks, S., Polycystic ovary syndrome. N. Engl. J. Med 333 (1995), 853-861.
2. Stein, I.F., Leventhal, M.L., Amenorrhea associated with bilateral polycystic ovaries. Am. J. Obstet. Gynecol 29 (1935), 181-191.
3. Norman, R.J., Clark, A.M., Obesity and reproductive disorders: a review. Reprod. Fertil. Dev 10 (1998), 55-63.
4. Franks, S., Hamilton Fairley, D., The role of body weight and metabolic anomalies in ovulation induction. Contracept. Fertil. Sex 22 (1994), 178-179.
5. Pasquali, R., et al. Clinical and hormonal characteristics of obese amenorrheic hyperandrogenic women before and after weight loss. J. Clin. Endocrinol. Metab 68 (1989), 173-179.
6. Hamilton-Fairley, D., et al. Association of moderate obesity with a poor pregnancy outcome in women with polycystic ovary syndrome treated with low dose gonadotrophin. Br. J. Obstet. Gynaecol 99 (1992), 128-131.
7. Pettigrew, R., Hamilton Fairley, D., Obesity and female reproductive function. Br. Med. Bull 53 (1997), 341-358.
8. Richardson, M.R., Current perspectives in polycystic ovary syndrome. Am. Fam. Phys 68 (2003), 697-704.
9. Inzucchi, S.E., et al. Efficacy and metabolic effects of metformin and troglitazon in type II diabetes mellitus. N. Engl. J. Med 338 (1998), 721-867.
10. Bailey, C.J., Puah, J.A., Effect of metformin and glucose metabolism in mouse soleus muscle. Diabetes Metab 12 (1986), 212-218.
11. Hasegawa, I., et al. Effect of troglitazone on endocrine and ovulatory performance in women with insulin resistance-related polycystic ovary syndrome. Fertil. Steril 71 (1999), 323-327.